Who Determines Substitution Factors?
What is an Invention?
How Big Should My First Patent Be?
Forward Citation Landscape
PTAB Timing Trial Dynamics
Common Reasons Trademarks Are Rejected
Limited Valuable Patents in Technology Area
Why Are Biologicals so Important?
Forms of Confidential Information
Unlicensed Source Codes
Trademarks and Brand Value
Intent of Patent Laws
Helping In-House Council
What Do I Give up in Getting My Patent?
Inter Partes Review
Importance of Post-Grant Proceedings
Impact of PTAB
Rewards of the Practice
How to Remedy Unwanted Disclosure of Confidential Information
Biologics Price Competition and Innovation Act
Requirements to Receive a Patent
What Doesn't a Patent Provide?
"Whats" - Audit Action Sheet
Practicing an Invention
Tracking Work History
Impact of Post-Grant Proceedings
Should IP be Part of Our Business Plan?
How to Fix the Knowledge Gap
First Item on IP To-Do List
BioSimilar Patenting Litigation Involving Large Amounts of Money
Patent Analytics and Competition
Cost of Registering a Trademark
How is Open Source Software Enforced?
Attributes of a Good Patent
Patent Citation Ranking
Impact of US Hatch Waxman Act 1984
Claim Maps and BioSimilars
What Should a Company Patent?
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Hiring Patent Council
Repeating Competitor Audits
Researching Competitors' IP
Third Party Confidentiality
Biologics vs Small Molecules
Prior Art Challenge
Freedom to Operate
Implementing a Value-Driven Portfolio Process
Using Product Association with IP Assets
What is a Patent?
Interpretational Differences Between Prosecution and Litigation
Low Risk Joint Ventures
Broad Patent Claim
Golden Rule of Auditing a Patent Portfolio
The Case of the Joint Marketing Agreement Gone Bad
Effective Stay Strategy
What is Prior Art?
Segmenting a Portfolio
Goal of a Value-Driven Patent Portfolio
Patent Ownership and Patent Profile Analytics
Engineers Not Understanding Patents
Picking a Domain Name
Standard for Getting a Patent
Get Your Assignments Straight - Contribution of Owners
Why Perform Risk Profile?
Inventors and Patent Analytics
Intellectual Property Protection
Date of First Use
Meet Mark Stignani
The Five Components of an Open Source Software Policy
FDA Guidelines for Demonstrating Biosimilarity
Merely Descriptive Refusal
Consequences of a Poorly Drafted Patent
Are BioSimilars Being Approved in the US?
Independent Claim vs Dependent Claim
Patent Profile Analytics and Researchers
What Makes Schwegman, Lundberg & Woessner Different?
Categories of Marks
"How Much" - Audit Action Sheet
How Long Does an FTO Take?
Attorneys Not Understanding the Market
Freedom To Operate vs Clearance
Patent Status Updates
Prior Art and Rejections
Patent Profile Analytics and Engineers
Value Management and Risk Management
Open Source Software
A Better Way to Allocate Patent Application Budgets
First Step in Performing a Patent Portfolio Audit
Domain Registration Considerations
Raising Good Prosecution Visibility
Ideal Patent Strategy
How Does the Knowledge Gap Worsen Over Time?
PTAB Final Argument Trial Dynamics
Equal Value Patents
Claim Abstraction Theory
Scope Concepts and Headnotes
Audit Action Sheet
How is the Entire Patent Considered Prior Art?
Considerations Before Hiring IP Council
Tools for Auditing a Patent Portfolio
Joint Venture and Financial Agreements
How Should IP be Considered for Growth?
NDAs and Customers
Provisional vs Non-Provisional Patent
Secondary Meaning of a Trademark
What is a Trademark?
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
How Should IP be Considered for Acquisition?
Becoming a Patent Lawyer
Factors That Cause a Patent to Decline in Value
How Do Patent Portfolio Values Become Concentrated over Time?
Moderate Risk Joint Ventures
Infringing on Another Patent
Calculating New Investments
Cost/Value Curve of a High Level Patent
"Wheres" - Audit Action Sheet
What is a BioSimilar?
How can OSS Negatively Affect a Company?
Post-Grant Options and Estoppel
Importance of Freedom To Operate
Qualifying for a Patent
Why Do You Enjoy Being a Lawyer?
Demonstrating BioSimilarity Under U.S. Law
Discovering Annuity Information
How is Schwegman Lundberg & Woessner Different?
How Much Does it Cost to Get a Patent?
Confidential Information and Business Damage
Do Narrow Patents Add Value to a Portfolio?
Importance of Getting a Patent
What is a Patent Portfolio?
Advantages of Registering a Trademark
What Engineers Can Learn from Patent Profile Analytics
Is A United States Registered Trademark Effective in Other Countries?
Naming Problems with BioSimilars
Benefits of Audit Action Sheet
How Does the Knowledge Gap Develop?
Approvals of BioSimilars in Europe
Open Source Initiative
What Does an Audit Action Sheet Look Like?
"Whens" - Audit Action Sheet
When is a House like a Patent?
Patents and Other Forms of Intellectual Property Protection
Determining Likelihood of Confusion
The Different Types of Marks
NDAs and Computer Codes
Geographic Insight and Patent Profile Analytics
Patent Profile Analytics and Managers
Types of Inventions That Are Patentable
Infringement on the Rights of Other Patents
Patent Strategy Considerations
Downside of Static Budget Allocation for Patents
Meet David Black
How do Patent Prosecution Services Vary in Value?
Signing an NDA
Post-Grant Proceedings and Patent Enforcement
Common Law Trademark Rights
Consequences of Disclosing Confidential Information
Am I Required to Search for Prior Art?
When to Do a Freedom to Operate
Proper Way to Use a Trademark
Most Common Client Question
Types of Intellectual Property Protection
Is There Still a Place for Traditional Re-Examination?
What to Do When First Selecting a Mark
Patent Portfolio and Budgets/Spending
Value Management and Cash Flow
Joint Venture Pitfalls
Purposes of a Trademark
Improperly Marked Product
Factors That Make a Patent Valuable
IP Registration Density
Mitigating Risks of Past Damages
Seeking Money from Investors
Covered Business Method Review
Contractual Intellectual Property Rights
Cited Art Landscape
What is a BioSimilar Product Under US Law?
Process for Registering a Trademark in the United States
Challenges When Dealing with Patent Matters
Trade Names vs Trademarks
5 Year View Point
Trade Name Protection and Trademark Protection
"Claims" of a Patent
By the Numbers Overview
Patent Owner Rights
Joint Venture Ground Rules
Prior Art in Prosecution vs Prior Art in Litigation
Auction Audit Sheet - Key Issues to Address
"Who" - Audit Action Sheet
Risks of OSS
Assessing Executive Experience
Freedom To Operate
Limiting Issues Defined in District Court
Wasting Money on Low-Value Patents
Evaluation Agreement and Computer Codes
Different Parts of a Patent Document
Trademark Filing Considerations
High Risk Joint Ventures
Improving Patent Portfolio Value
Why Is Executing an NDA Not Enough?
Reasons to Consider Joint Ventures
Budgeting for Drafting and Prosecution
Refused Trademark Recourse
Two Main Value Drivers
Outside of Law
Post-Grant Options and Cost
Patent Examination Process
Renewing a Trademark Registration
Value Management Lifecycle
How is Open Source Incorporated into Software?
Marking a Product
Joint Ventures and Dispute Resolution
What Should a Company Understand at the End of an IP Audit?
The Advantage of Filing First
Important Attributes to Being a Successful Patent Lawyer
Portfolio Dashboard - Inventor Information
Picking a Trademark
OSS Licensing Conditions
Freedom to Operate (FTO) Process
Post-Grant Options and Grounds of Challenge
Attorneys and Patent Profile Analytics
Patent Trial and Appeal Board
How to Navigate BioSimilar Challenges
Inventorship vs Ownership
What IP Should I Spend Money on First?
Litigation and BioSimilar Patenting
Value-Driven Patent Portfolio
A Less Expensive Alternative
Risks of Not Patenting
Steps to Obtaining a Patent
Cost/Value Curve of Patent a Portfolio
Patents and Practicing an Invention
4 Ways to Prepare your Patent Portfolio for Battle.
Rebutting a Merely Descriptive Refusal
Why Should Claims Not Be Read on the Prior Art?